Cita APA (7a ed.)

Askeland, F. B., Haukås, E., Slørdahl, T. S., Schjøll, D., Lysen, A., Hermansen, E., & Schjesvold, F. (2022). P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY. Wiley.

Cita Chicago Style (17a ed.)

Askeland, F. B., E. Haukås, T. S. Slørdahl, D. Schjøll, A. Lysen, E. Hermansen, y F. Schjesvold. P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY. Wiley, 2022.

Cita MLA (9a ed.)

Askeland, F. B., et al. P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY. Wiley, 2022.